Andrea Baragetti Redefines the Dialogue Between Heart and Kidney at EAS Milan
Andrea Baragetti, Associate Professor of Pharmacology at University of Milan, posted on LinkedIn:
”On the frontline of cardiovascular innovation
In Milan, at the European Atherosclerosis Society Advanced Course on Non-Classical Risk Factors, I had the privilege to stand among brilliant scientists and clinicians united by a single mission – to challenge what’s known and redefine the limits of cardiovascular and metabolic medicine.
Gratitude to the organizers and the European Atherosclerosis Society (EAS) for the opportunity to contribute with a talk on upfront therapeutic perspectives on cardio-renal syndrome – a field where the heart and kidney engage in a silent but relentless dialogue, and where every new insight can shift the balance between failure and recovery.
Science is a weapon, innovation is a creed.”
Keep up with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers